| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.04 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.081 | 0.05 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.05 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.05 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.05 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.08 | 0.05 |